Where Will Vertex Pharmaceuticals Be in 10 Years?

Vertex has a solid cystic fibrosis portfolio that generates billions of dollars in annual earnings -- and that’s set to continue for the long term.
The biotech, expanding into other treatment areas, is expecting a regulatory decision on a new potential blockbuster in a matter of days.